ArticleCancer imaging : the official publication of the International Cancer Imaging Society2026
Time-dependent diffusion MRI as in vivo histology: microstructural biomarkers for breast cancer diagnosis and prognostic stratification.
Article in Cancer imaging : the official publication of the International Cancer Imaging Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundTime-dependent diffusion MRI (TD-dMRI) holds potential for characterizing tumor cell properties; however, its utility in diagnosing various breast lesions and evaluating Ki-67 expression remains unexplored. This study aimed to assess the utility of TD-dMRI for distinguishing benign breast lesions, ductal carcinoma in situ (DCIS) and invasive breast carcinoma (IBC), and correlating its derived parameters with molecular subtypes and histopathological features.
methodsThis retrospective study enrolled participants with breast lesions who underwent oscillating and pulsed gradient encoded TD-dMRI and conventional multi-parametric MRI from May 2024 to January 2025. The imaging microstructural parameters using limited spectrally edited diffusion (IMPULSED) model was used to extract microstructural parameters, including mean cell diameter (Dmean), cellularity, intracellular volume fraction (Vin), and extracellular diffusivity (Dex). Histopathological results (molecular subtypes, Nottingham grade, and Ki-67 index) served as the reference standard. Statistical analyses comprised receiver operating characteristic (ROC) curve analysis, correlation tests, and intergroup comparisons.
resultsThis study included 104 patients with 108 breast lesions. Significant differences were observed in TD-dMRI parameters among benign breast lesions, DCIS and IBC, and between high and low expression of Ki-67 (P < .05). IBC exhibited the highest cellularity (3.30 ± 0.77 μm− 1), the largest Dmean (10.26 ± 1.53 μm), the highest Vin (30.42% ± 7.33%), and the lowest ADC value (0.83 ± 0.10 × 10− 3mm2/s). High Ki-67 expression exhibited higher cellularity (3.38 ± 0.70 μm− 1), Dmean (10.51 ± 1.38 μm), Vin (31.10 ± 6.97%) and lower Dex (2.11 ± 0.22 µm2/ms) and ADC value (0.84 ± 0.11 × 10− 3mm2/s) compared to low Ki-67 expression. ADCDWI demonstrated the highest diagnostic performance in identifying benign lesions (AUC = 0.886) and IBC (AUC = 0.917). Vin showed considerable efficacy in distinguishing high Ki-67 expression from low Ki-67 expression (AUC = 0.801). Luminal B tumors displayed higher Dmean (10.63 ± 1.47 μm), Vin (31.48 ± 7.96%), lower ADC (0.82 ± 0.11 × 10− 3mm2/s) and Dex (2.07 ± 0.28 µm2/ms).
conclusionTD-dMRI noninvasively quantifies microstructural features of breast lesions, improving diagnostic accuracy and providing valuable correlations with molecular subtypes and proliferative activity, with promise for clinical translation in precision oncology.
trial registrationRegistry: Zhongnan Hospital of Wuhan University, TRN: 2,025,221 K, registration date: 27 August 2025, retrospectively registered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.